Sugentech Past Earnings Performance

Past criteria checks 0/6

Sugentech has been growing earnings at an average annual rate of 6.3%, while the Medical Equipment industry saw earnings growing at 18.7% annually. Revenues have been growing at an average rate of 0.4% per year.

Key information

6.3%

Earnings growth rate

9.0%

EPS growth rate

Medical Equipment Industry Growth22.7%
Revenue growth rate0.4%
Return on equity-11.6%
Net Margin-124.8%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Does Sugentech (KOSDAQ:253840) Have A Healthy Balance Sheet?

Jul 27
Does Sugentech (KOSDAQ:253840) Have A Healthy Balance Sheet?

We Like Sugentech's (KOSDAQ:253840) Returns And Here's How They're Trending

Apr 14
We Like Sugentech's (KOSDAQ:253840) Returns And Here's How They're Trending

Sugentech (KOSDAQ:253840) Seems To Use Debt Quite Sensibly

Mar 09
Sugentech (KOSDAQ:253840) Seems To Use Debt Quite Sensibly

If You Had Bought Sugentech (KOSDAQ:253840) Stock A Year Ago, You Could Pocket A 139% Gain Today

Feb 02
If You Had Bought Sugentech (KOSDAQ:253840) Stock A Year Ago, You Could Pocket A 139% Gain Today

Is Sugentech (KOSDAQ:253840) The Next Multi-Bagger?

Dec 29
Is Sugentech (KOSDAQ:253840) The Next Multi-Bagger?

Sugentech (KOSDAQ:253840) Seems To Use Debt Quite Sensibly

Dec 03
Sugentech (KOSDAQ:253840) Seems To Use Debt Quite Sensibly

Revenue & Expenses Breakdown

How Sugentech makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KOSDAQ:A253840 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 249,707-12,11112,8063,567
30 Jun 247,078-14,08112,2033,773
31 Mar 247,555-16,44612,6963,565
31 Dec 237,132-17,23812,8853,621
30 Sep 236,976-36,50412,0324,346
30 Jun 2314,207-27,33312,6284,762
31 Mar 2334,997-12,95812,5315,296
31 Dec 22101,39926,71712,2855,156
30 Sep 22125,13762,75412,5725,832
30 Jun 22150,60179,77711,2505,168
31 Mar 22134,10565,43410,0474,382
31 Dec 2177,20136,1528,5983,916
30 Sep 2164,11028,2537,3283,280
30 Jun 2133,990-19,3655,3783,045
31 Mar 2151,856-33,3135,0413,339
31 Dec 2041,352-41,0185,1403,388
30 Sep 2029,818-49,1943,9483,225
30 Jun 2026,482-23,1484,1183,193
31 Mar 203,424-10,3804,4762,941
31 Dec 193,845-9,5634,0552,659
30 Sep 194,626-5,2394,2332,285
31 Dec 185,449-40,9173,5231,689

Quality Earnings: A253840 is currently unprofitable.

Growing Profit Margin: A253840 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: A253840 is unprofitable, but has reduced losses over the past 5 years at a rate of 6.3% per year.

Accelerating Growth: Unable to compare A253840's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A253840 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-13.3%).


Return on Equity

High ROE: A253840 has a negative Return on Equity (-11.59%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 12:57
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sugentech Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution